{
    "Trade/Device Name(s)": [
        "Fastect\u00ae II PPX Drug Screen Dipstick",
        "Fastect\u00ae II Drug Screen Dipstick",
        "QuickTox\u00ae Drug Screen Dipcard"
    ],
    "Submitter Information": "Branan Medical Corporation",
    "510(k) Number": "k122752",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041685"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXN"
    ],
    "Summary Letter Date": "January 30, 2013",
    "Summary Letter Received Date": "January 03, 2013",
    "Submission Date": "January 02, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Propoxyphene test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Propoxyphene",
        "THC (11-nor-\u03949-Tetrahydrocannabinol-9-carboxylic acid)",
        "Cocaine (Benzoylecgonine)",
        "Opiates (Morphine)",
        "Methamphetamine",
        "Amphetamine",
        "Phencyclidine",
        "Oxazepam",
        "Secobarbital",
        "Methadone",
        "Nortriptyline",
        "MDMA (3,4-methylenedioxymethamphetamine)",
        "Oxycodone",
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Competitive immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic testing"
    ],
    "Submission Type(s)": [
        "Dipstick",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for Branan Medical Corporation multi-drug screen dipsticks and dipcards for rapid qualitative detection of propoxyphene and other drugs in human urine",
    "Indications for Use Summary": "Visual qualitative in vitro diagnostic tests for rapid detection of propoxyphene and multiple drugs/metabolites in human urine at stated cutoff concentrations, for prescription point-of-care use only; results are preliminary and require confirmatory testing for positives",
    "fda_folder": "Toxicology"
}